Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Watch the Recording What Youll Learn Current payer perspectives on GLP-1 coverage for obesity treatment and type 2 diabetes management Emerging affordability thresholds and price sensitivity among plans Strategies for addressing off-label type 2 diabetes GLP-1 use and its financial impact Approaches to prior authorization protocols and BMI requirements for obesity GLP-1s The role of weight management vendors in comprehensive obesity GLP-1 coverage strategies Market insights on compounded GLP-1 products and their place in benefit design Attendees will gain actionable strategies and insights to optimize their pharmacy benefit design for these high-impact medications in 2025 and beyond
doi: 10.1016/j.molimm.2019.09.021 115 BourantasCVZanchinTSakellariosAKaragiannisARamasamyAYamajiKet al
Regular use can help you achieve smooth, radiant skin over time
Source : NEJM SURMOUNT-1 Trial Over 90% achieved 5%+ weight loss 9 out of 10 participants lost at least 5% of their body weight using GLP-1 + GIP a powerful early milestone toward long-term success
Sullivan, G
US$ 23.00
US$ 22.36
US$ 22.09
US$ 22.23
